Oligonucleotides for Treatment of Angiopoietin Like 4 (ANGPTL4) Related Diseases
Copyright © Targeted News Service 2026
2026-07-07
ALEXANDRIA, Virginia, July 7 -- EMPIRICO INC., San Diego, California has been assigned a patent (No. US 12674165 B2, initially filed May 4, 2022) developed by five inventors Omri Gottesman, San Diego, California; Shannon Bruse, San Diego, California; Brian Cajes, San Diego, California; David Lewis, Madison, Wisconsin; and David Rozema, Cross Plains, Wisconsin, for "Oligonucleotides for treatment of angiopoietin like 4 (ANGPTL4) related diseases." . . .
